We are excited to introduce our award-winning CompoZr® Breast Cancer Cell Lines. By creating these human cell lines with CompoZr Zinc Finger Nucleases (ZFNs), we are able to make targeted and heritable deletions, integrations and modifications to the genome of these cell lines.
Get common cancer targets like TP53, PTEN and HER2 knock out cell lines ready for your experiments. These cell lines even come with their parental cells, giving you an excellent control.
With our CompoZr Breast Cancer Cell Lines you can do basic research, drug discovery and drug development targeting any gene in a clean way. Using knockout cell lines you can study the response of each mutation to a drug, giving you a test scenario where you have “mini-patients” in your test tube. With these cell lines, academic researchers can conduct complicated genetic experiments in human cells without having to resort to mouse genetics projects.
The development of personalized medicine can now be accelerated thanks to these genetically defined cell lines. The ease with which genetically modified cell lines can be created with CompoZr ZFNs now enables you to get your customized cell lines with your favorite disease-relevant mutation incorporated into it. This will enable profiling patient genotypes that are responsive to a drug therapy and to determine genotypes that are resistant to a drug regimen driving the development of personalized medicine.
If you are interested in learning more about our new CompoZr Breast Cancer Cell Lines, complete this survey and one of our Technical Sales Specialists will contact you directly.
To celebrate the launch we are giving away a limited number of BioPink T-shirts to respondents of the survey, to show our support for Breast Cancer research.